df: JAMA Breast cancer

In RPEXE.RPEXT: Reduced Piecewise Exponential Estimate/Test Software

Description

A dataset containing predictions for chemo-censitivity and pathological response from Hatzis (2011)

Usage

data(df)

Details

• validate: Validation status

• drfs: Censoring status; 0=censored, 1=event.

• drfs.time: Time to event or censoring

• er.status: ER status, P=positive, N=negative

• chemo.pred: Prediction for chemo sensitivity from the ACES predictor, sensitive or insensitive

• pre.N: Prediction of nodal status

• pCR.RD: pathological complete response (pCR) or residual disease (RD)

• pre.grade: prediction of tumor grade

• pre.T: T stage prediction

• dlda30: DLDA30 prediction for the pathological response.

References

[1] Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873–1881.

RPEXE.RPEXT documentation built on July 1, 2020, 6:02 p.m.